Physico-chemical solid-state characterization of omeprazole sodium: Thermal, spectroscopic and crystallinity studies

Journal of Pharmaceutical and Biomedical Analysis

Volumn 49, Issue 1, 2009, Pages 72-80

  Murakami, Fabio S ^a   Lang, Karen L ^a   Mendes, Cassiana ^a   Cruz, Ariane P ^a   Filho, Marco A S Carvalho ^b   Silva, Marcos A S ^a  

^a Universidade Federal   (Brazil)

^b POSITIVO UNIVERSITY   (Brazil)

Author keywords

Crystal structure; Omeprazole sodium; Solid state characterization

Indexed keywords

OMEPRAZOLE; WATER;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSE REFLECTANCE SPECTROSCOPY; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID STATE; THERMAL ANALYSIS; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG STABILITY; ENZYME INHIBITORS; HOT TEMPERATURE; HYDROGEN BONDING; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OMEPRAZOLE; PHYSICOCHEMICAL PHENOMENA; POWDERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS; STEREOISOMERISM; THERMOGRAVIMETRY; TITRIMETRY; WATER; X-RAY DIFFRACTION;

EID: 58249134041     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.10.005     Document Type: Article

References (38)

1. Hoover J.E. Remington the Science and Practice of Pharmacy. 21st ed. (2005), Lippincott, Williams & Wilkins, Philadelphia pp. 1294-1317
2. Hoogerwerf W.A., and Pasricha P.J. In: Goodman A.G. (Ed). The Pharmacological Basis of Therapeutics. 11th ed. (2006), Mc Graw Hill, New York 967-981
3. Olbe L., Carlsson E., and Lindberg P. Nat. Rev. Drug Discov. 2 (2003) 132-139
4. Roche V.F. Am. J. Pharm. Educ. 70. (2006) article 101, 1-11
5. Martindale S. The Complete Drug Reference. 33rd ed. (2002), Pharmaceutical Press, London, Thomson Micromedex, Greenwood Village
6. Dellagreca M., Iesce M.R., Previtera L., Rubino M., Temussi F., and Brigante M. Chemosphere 63 (2006) 1087-1093
7. British Pharmacopoeia, The Stationery Office on behalf of the Medicines and Healthcare products Regulatory Agency, CD-ROM version 11.0, London, 2007.
8. Yang R., Schulman S.G., and Zavala P.J. Anal. Chim. Acta 481 (2003) 155-164
9. Mathew M., Das Gupta V., and Bailey R.E. Drug Dev. Ind. Pharm. 21 (1995) 965-971
10. Davidson A.G., and McCallum A. Drug Dev. Ind. Pharm. 22 (1996) 1173-1185
11. Riedel A., and Leopold C.S. Drug Dev. Ind. Pharm. 31 (2005) 151-160
12. Murakami F.S., Cruz A.P., Pereira R.N., Valente B.R., and Silva M.A.S. J. Liq. Chromatogr. R. T. 30 (2007) 113-121
13. Markovic N., Agotonovic-Kustrin S., Glass B., and Prestidge C.A. J. Pharm. Biomed. Anal. 42 (2006) 25-31
14. Brittain H.G. Pharm. Technol. 5 (2001) 22-30
15. Gandhi R., Pillai O., Thilagavathi R., Gopalakrishnan B., Kaul C.L., and Panchagnula R. Eur. J. Pharm. Sci. 16 (2002) 175-184
16. Yu L. Ad. Drug Deliv. Rev. 48 (2001) 27-42
17. Te R.L., Griesser U.J., Morris K.R., Byrn S.R., and Stowell J.G. Cryst. Growth Des. 3 (2003) 997-1004
18. Vogt F.G., Brum J., Katrincic L.M., Flach A., Socha J.M., Goodman R.M., and Haltiwanger R.C. Cryst. Growth Des 6 (2006) 2333-2354
19. Byrn S.R., Xu W., and Newman A.W. Adv. Drug Deliv. Rev. 48 (2001) 115-136
20. Giron D. Pharmaceut. Sci. Technol. 1 (1998) 191-199
21. Tomassetti M., Catalani A., Rossi V., and Vecchio S. J. Pharm. Biomed. Anal. 37 (2005) 949-955
22. Ruiz M.A., Reyes I., Parera A., and Gallardo V. J. Therm. Anal. Calorim. 51 (1998) 29-35
23. Figueiras A., Carvalho R.A., Ribeiro L., Torres-Labandeira J.J., and Veiga F.J.B. Eur. J. Pharm. Biopharm. 67 (2007) 531-539
24. Ozawa T. J. Therm. Anal. Calorim. 60 (2000) 887-894
25. Silva M.A.S., Kelmann R., Foppa T., Cruz A.P., Bertol C., Sartori T., Granada A., Carmignan F., and Murakami F.S. J. Therm. Anal. Calorim. 87 (2007) 463-467
26. Mura P., Gratteri P., and Faucci M.T. J. Therm. Anal. Calorim. 68 (2002) 541-551
27. Clarke's, Analysis of Drug and Poisons, Cd-Rom version, Pharmaceutical Press, London, 2004.
28. Agatonovic-Kustrin S., Markovic N., Ginic-Markovic M., Mangana M., and Glass B.D. J. Pharm. Biomed. Anal. 48 (2008) 356-360
29. Giron D., Goldbronn Ch., Mutz M., Pfeffer S., Piechon Ph., and Schwab Ph. J. Therm. Anal. Calorim. 68 (2002) 453-465
30. Stephenson G.A., Forbes R.A., and Reutzel-Edens S.M. Adv. Drug Deliv. Rev. 48 (2001) 67-90
31. Phadnis N.V., Cavatur R.K., and Suryanarayanan R. J. Pharm. Biomed. Anal. 15 (1997) 929-943
32. Ruland W. Acta Crystallogr. 14 (1961) 1180-1185
33. Zimeri J.E., and Kokini J.L. Carbohydr. Polym. 48 (2002) 299-304
34. Cardoso T.M., Rodrigues P.O., Stulzer H.K., and Silva M.A.S. Drug Dev. Ind. Pharm. 31 (2005) 631-637
35. Ozawa T. Bull. Chem. Soc. 38 (1965) 1881-1886
36. Bugay D.E. Adv. Drug Deliv. Rev. 48 (2001) 43-65
37. Ohishi H., In Y., Ishida T., and Inoue M. Acta Crystallogr. 45 (1989) 1921-1923
38. Deng J., Chi Y., Fu F., Cui X., Yu K., Zhu J., and Jiang Y. Tetrahedron-Asymmetry 11 (2000) 1729-1732